Drug reference

mrna-1273

mRNA vaccine · vaccine

mRNA vaccinevaccine

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

mRNA-1273 is a nanoparticle encapsulated mRNA vaccine that encodes a full-length SARS-CoV-2 spike protein, stimulating an immune response to provide protective immunity.

Indications

prevention of severe or fatal COVID-19

Dosing

Adult: requires two doses, 28 days apart

Related guidelines

Stroke and TIA — secondary prevention

AHA · Neurology · 2021

Tobacco-related cancer prevention

ICMR · Oncology · 2021

Cardiovascular disease prevention

ESC · Cardiology · 2021

Primary prevention of cardiovascular disease

AHA · Cardiology · 2019

Infective endocarditis prevention

ADA_DENTAL · Dentistry · 2015

Other mRNA vaccine drugs

Ask House about mrna-1273

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team